NCT05882773
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +18 more
- Locations
-
- Department of Medicine, Queen Mary Hospital Hong Kong
Clinical trial condition
Thrombocythemia, Essential
Explore clinical trials studying Thrombocythemia, Essential. Study availability and eligibility vary by location and protocol.
185 public trials
31 recruiting studies
Thrombocythemia, Essential trial results
Not yet recruiting
CRETA (Clopidogrel Responsiveness in Essential ThrombocithemiA)
NCT07645755
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
- Locations
-
- Azienda USL di Pescara - Ospedale Santo Spirito Pescara, Italy
- AOU Città della Salute e della Scienza di Torino Torino, Italy
Not yet recruiting
ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia
NCT07518940
- Conditions
- Behavior, Blood Coagulation Disorders, Blood Platelet Disorders, +26 more
- Locations
-
- AO Ordine Mauriziano di Torino Torino, To, Italy
Not yet recruiting
WELL-MPN: A Digital Lifestyle App for Patients With MPNs
NCT07349134
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
- Locations
-
- Mass General Brigham Boston, Massachusetts, United States
Not yet recruiting
Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History
NCT06923670
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
- Locations
-
Not specified
Active, not recruiting
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
NCT06456346
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
- Locations
-
- Palo Verde Cancer Specialists ( Site 0052) Glendale, Arizona, United States
- Los Angeles Cancer Network ( Site 0025) Glendale, California, United States
- Stanford Cancer Center ( Site 0024) Palo Alto, California, United States
- Exempla Lutheran Medical Center ( Site 0014) Golden, Colorado, United States
Active, not recruiting
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
NCT06079879
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
- Locations
-
- Palo Verde Hematology/ Oncology Center, Ltd. ( Site 3496) Glendale, Arizona, United States
- Los Angeles Cancer Network ( Site 3491) Glendale, California, United States
- Stanford Cancer Institute ( Site 0107) Stanford, California, United States
- The Lundquist Institute ( Site 3423) Torrance, California, United States
Active, not recruiting
The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia
NCT02577926
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
- Locations
-
- Universitätsmedizin Mannheim III. Medizinische Klinik Hämatologie und Internistische Onkologie Mannheim, Baden-Wurttemberg, Germany
- Universitätsklinikum Ulm Klinik für Innere Medizin III Ulm, Baden-Wurttemberg, Germany
- Rems-Murr Klinikum Winnenden Winnenden, Baden-Wurttemberg, Germany
- Studienzentrum Aschaffenburg Aschaffenburg, Bavaria, Germany
Active, not recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
NCT05936359
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +8 more
- Locations
-
- Royal Brisbane and Women'S Hospital Herston, Queensland, Australia
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Peter Maccallum Cancer Centre Melbourne, Victoria, Australia
- The Alfred Hospital Melbourne, Victoria, Australia
Active, not recruiting
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
NCT00935090
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States